Skip to main content
. 2015 Feb 11;10(2):e0116223. doi: 10.1371/journal.pone.0116223

Table 4. Results of laboratory experiment statistical analyses.

Year Initial disease status Disease metric Test df F P
2009 uninfected Total prevalence diel-cycling hypoxia 2,12 9.19 0.004
MHprevalence diel-cycling hypoxia 2,12 3.72 0.055
intensity diel-cycling hypoxia 2,11* 0.15 0.277
mortality diel-cycling hypoxia 2,12 0.08 0.927
shell growth diel-cycling hypoxia 2,12 0.66 0.534
2009 infected Total prevalence diel-cycling hypoxia 2,12 0.05 0.954
MHprevalence diel-cycling hypoxia 2,12 0.03 0.972
intensity diel-cycling hypoxia 2,12 0.15 0.861
mortality diel-cycling hypoxia 2,12 0.98 0.403
shell growth diel-cycling hypoxia 2,12 0.53 0.600
2010 uninfected (ANOVA) Total prevalence diel-cycling hypoxia 2,12 0.03 0.720
MHprevalence diel-cycling hypoxia 2,12 0.05 0.95
intensity diel-cycling hypoxia 2,12 0.56 0.587
mortality diel-cycling hypoxia 2,12 0.08 0.924
shell growth diel-cycling hypoxia 2,12 13.81 0.001
wet weight growth diel-cycling hypoxia 2,12 4.13 0.043
uninfected (ANCOVA) Total prevalence Model 7,7 5.20 0.02
Diel-cycling hypoxia 2,7 5.97 0.031
P. marinus density in paired tank 1,7 15.24 0.006
Room position (block) 4,7 3.26 0.083
infected Total prevalence diel-cycling hypoxia 2,12 4.17 0.042
MHprevalence diel-cycling hypoxia 2,12 0.13 0.881
intensity diel-cycling hypoxia 2,12 0.85 0.454
mortality diel-cycling hypoxia 2,12 3.98 0.047
shell growth diel-cycling hypoxia 2,12 1.42 0.280
wet weight growth diel-cycling hypoxia 2,12 0.79 0.477

One-way ANOVA was used to test effects of diel-cycling hypoxia on total prevalence and MHprevalence of P. marinus infections, as well as oyster mortality in both years. Nested ANOVA was used to test for effects on infection intensity and oyster growth. In addition ANCOVA was used to test for effects of diel-cycling hypoxia on total prevalence and growth in 1yo oysters for the 2010 experiment. For 3yo oysters in 2010, significant DO effects do not provide evidence for a negative effect of diel-cycling hypoxia; growth in the 0.5 mg l-1 treatment did not differ from that in controls, and mortality was higher in controls than in the 0.5 mg l-1 treatment.

*Control replicate with zero prevalence was not included in intensity analysis, resulting in a lower df.